Latchbio Raises $28M Series A To Bring A Modern Data Analysis Stack To Biologists

Jun 02, 2022•about 3 years ago

Amount Raised

$28 Million

Round Type

series a

San Francisco

Description

LatchBio, a company accelerating the pace of scientific progress by enabling researchers to store and analyze data without touching code or cloud infrastructure, today announced a $28 million Series A round co-led by Coatue and existing investor Lux Capital. Hummingbird Ventures, Caffeinated Capital, and existing investors Haystack and Fifty Years also participated.

Company Information

Company

Latch Bio

Location

San Francisco, California, United States

About

LatchBio is a San Francisco-based company on a mission to build and disseminate the data infrastructure for the biocomputing revolution. The company’s cloud-based platform offers no-code bioinformatics for scientists seeking to store, transform and visualize their data. Through any web browser, the global scientific community can quickly access popular bioinformatics pipelines and data visualization tools. For company updates, visit latch.bio.

FundzWatch™ Score

Medium Activity

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech